Leiomyosarcoma causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Overview: ==
== Overview: ==
Exact cause of leiomyosarcoma is not clearly evident.
Leimoyosarcoma is a malignant aggressive form of soft tissue [[sarcoma]] which can invlove [[muscle cells]]. [[Uterine]] leiomyosarcoma is a rare disease, involves uterine [[smooth muscle cells]]. Exact cause of leiomyosarcoma is not well understood but there is theory which finds leiomyosarcoma, arising from benign [[tumor]] of uterine [[smooth muscle]], called [[leiomyoma]]. It is believed that it may arie denovo or due to [[genetic]] alterations.
 
__NOTOC__
__NOTOC__
{{Leiomyosarcoma}}
{{Leiomyosarcoma}}


== Causes: ==
== Causes: ==
Exact cause of leiomyosarcoma is not clearly evident.However following points are considered regarding causes<ref name="pmid29780656">{{cite journal| author=Crystal JS, Korderas K, Schwartzberg D, Tizio SC, Zheng M, Parker G| title=Primary Leiomyosarcoma of the Colon: A Report of Two Cases, Review of the Literature, and Association with Immunosuppression for IBD and Rheumatoid Arthritis. | journal=Case Rep Surg | year= 2018 | volume= 2018 | issue=  | pages= 6824643 | pmid=29780656 | doi=10.1155/2018/6824643 | pmc=5892970 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29780656  }}</ref>:
Exact cause of leiomyosarcoma is not clearly unerstood, however following points are considered regarding causes:<ref name="pmid19051832">{{cite journal |vauthors=Indraccolo U, Luchetti G, Indraccolo SR |title=Malignant transformation of uterine leiomyomata |journal=Eur. J. Gynaecol. Oncol. |volume=29 |issue=5 |pages=543–4 |date=2008 |pmid=19051832 |doi= |url=}}</ref><ref name="pmid29780656">{{cite journal| author=Crystal JS, Korderas K, Schwartzberg D, Tizio SC, Zheng M, Parker G| title=Primary Leiomyosarcoma of the Colon: A Report of Two Cases, Review of the Literature, and Association with Immunosuppression for IBD and Rheumatoid Arthritis. | journal=Case Rep Surg | year= 2018 | volume= 2018 | issue=  | pages= 6824643 | pmid=29780656 | doi=10.1155/2018/6824643 | pmc=5892970 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29780656  }}</ref><ref name="pmid26097728">{{cite journal |vauthors=Duffaud F, Ray-Coquard I, Salas S, Pautier P |title=Recent advances in understanding and managing leiomyosarcomas |journal=F1000Prime Rep |volume=7 |issue= |pages=55 |date=2015 |pmid=26097728 |pmc=4447031 |doi=10.12703/P7-55 |url=}}</ref>
* Although not proven but some reasearchers believes that it could be a malignant transformation of the fibroid( leiomyoma).
* Studies revealed that the [[PI3K]]/[[AKT]]/[[mTOR]], [[estrogen]]-mediated [[S-phase]] entry and [[DNA]] damage response signaling pathways, for which inhibitors have already been developed and approved, frequently harbored genetic changes.
* It may arise denovo or can be due to the genomic instability. However molecular mechanism of tumorigenesis driven by genomic and genetic aberration is yet to be elucidated.
 
* Over expression of the protooncogene C-myc is seen in 50% of the cases.
* Although not proven but some reasearchers believes that it could be a malignant transformation of the [[fibroid]] ([[leiomyoma]]).
* Retinobalstoma gene discrepancies are also seen in 90% of cases.
* It may arise denovo or can be due to the [[genomic]] instability but the [[molecular]] mechanism is not quite well endrstood.  
* P16 chromosomal deletion causes loss of tumor suppression and so is involved in the development of leiomyosarcoma.
* Over expression of the [[protooncogene]] [[C-myc]] is seen in some of the cases.
* P53 gene mutation is also frequently seen in uterine leiomyosarcoma.
* [[Retinobalstoma]] gene discrepancies are also seen in 90% of cases.
* [[P16]] [[chromosomal]] deletion causes loss of [[tumor suppression]] and so is involved in the development of leiomyosarcoma.
* [[P53]] gene [[mutation]] is also frequently seen in uterine leiomyosarcoma.
* [[Epstein Barr virus|Epstein-Barr virus]] ([[EBV]]) infection, in the setting of severe [[immunosuppression]], has been associated with leiomyosarcomas.  


==References==
==References==

Latest revision as of 20:33, 14 March 2019

Overview:

Leimoyosarcoma is a malignant aggressive form of soft tissue sarcoma which can invlove muscle cells. Uterine leiomyosarcoma is a rare disease, involves uterine smooth muscle cells. Exact cause of leiomyosarcoma is not well understood but there is theory which finds leiomyosarcoma, arising from benign tumor of uterine smooth muscle, called leiomyoma. It is believed that it may arie denovo or due to genetic alterations.


Leiomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leiomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leiomyosarcoma causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leiomyosarcoma causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leiomyosarcoma causes

CDC on Leiomyosarcoma causes

Leiomyosarcoma causes in the news

Blogs on Leiomyosarcoma causes

Directions to Hospitals Treating Leiomyosarcoma

Risk calculators and risk factors for Leiomyosarcoma causes

Causes:

Exact cause of leiomyosarcoma is not clearly unerstood, however following points are considered regarding causes:[1][2][3]

  • Studies revealed that the PI3K/AKT/mTOR, estrogen-mediated S-phase entry and DNA damage response signaling pathways, for which inhibitors have already been developed and approved, frequently harbored genetic changes.

References

  1. Indraccolo U, Luchetti G, Indraccolo SR (2008). "Malignant transformation of uterine leiomyomata". Eur. J. Gynaecol. Oncol. 29 (5): 543–4. PMID 19051832.
  2. Crystal JS, Korderas K, Schwartzberg D, Tizio SC, Zheng M, Parker G (2018). "Primary Leiomyosarcoma of the Colon: A Report of Two Cases, Review of the Literature, and Association with Immunosuppression for IBD and Rheumatoid Arthritis". Case Rep Surg. 2018: 6824643. doi:10.1155/2018/6824643. PMC 5892970. PMID 29780656.
  3. Duffaud F, Ray-Coquard I, Salas S, Pautier P (2015). "Recent advances in understanding and managing leiomyosarcomas". F1000Prime Rep. 7: 55. doi:10.12703/P7-55. PMC 4447031. PMID 26097728.


Template:WikiDoc Sources